Bigul

Brightcom Group Ltd - 532368 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Comfort Fincap Ltd
17-08-2020
Bigul

Brightcom Group Ltd - 532368 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

The company has decided to arrange a virtual analyst meet with the select business analysts, who cover digital advertising globally. We plan to conduct this meet on the side lines of the well-known marketing summit 'Brandweek' conducted by Adweek between September 14-17, 2020. We will primarily focus presenting on our product offering and new features in the areas of Artificial Intelligence and Audio Advertising.
17-08-2020
Bigul

Brightcom Group Ltd - 532368 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 13, 2020 for M. Suresh Kumar Reddy
14-08-2020
Bigul

Brightcom Group Ltd - 532368 - An Overview Of Programmatic Advertising

Please find a presentation that gives a brief overview of Programmatic Advertising. Brightcom is considered one of the global leaders in Programmatic Advertising. Kindly disseminate the same to the shareholders of the Company through Stock Exchanges. The same is also being made available on the website of the Company at www.brightcomgroup.com.
03-08-2020
Bigul

Brightcom Group Ltd - 532368 - Compliances-Reg.24(A)-Annual Secretarial Compliance

Pursuant to Regulation 24A of the SEBI (LODR) Regulations, 2015, we are enclosing herewith the Annual Secretarial Compliance Report for the year ended March 31, 2020 issued by a Practicing Company Secretary.
30-07-2020
Bigul

Brightcom Group Ltd - 532368 - Statement Of Investor Complaints For The Quarter Ended June 2020

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- M MANOHARDesignation :- Company Secretary and Compliance Officer
20-07-2020

COVID-19: ICMR to conduct study on effectiveness of BCG vaccine among elders

The study will be carried out in Tamil Nadu, Maharashtra, Gujarat, Madhya Pradesh, Rajasthan and Delhi in approximately 1,500 healthy volunteers above 60-years of age, an ICMR scientist said.
18-07-2020
Bigul

Coronavirus vaccine: BCG vaccine trials start in Tamil Nadu; Bill Gates hails Indian pharma

Coronavirus vaccine news update: Bill Gates said in a documentary that India has a lot of capacity and that the Indian pharma industry is doing a lot of important things
16-07-2020
Next Page
Close

Let's Open Free Demat Account